Following new published evidence of apabetalone's benefit in COVID-19 (https://bit.ly/3sLCcBL), made in collaboration with researchers at QIMR Berghofer Medical Research Institute, Resverlogix is announcing the initiation of human clinical trials
CTV Calgary News at 5 covered the announcement in this clip, which originally aired on March 11, 2021
The meeting date assigned by the FDA is June 9, 2024
TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research a
Using the platform powered by advanced AI algorithms, Rakovina can quickly analyze billions of molecular structures ..
© 2023 Frontier Merchant Capital Group. All Rights Reserved.